Follow
Kieran Mace
Kieran Mace
CEO, Plinth Analytics
Verified email at picnichealth.com
Title
Cited by
Cited by
Year
A validated regulatory network for Th17 cell specification
M Ciofani, A Madar, C Galan, ML Sellars, K Mace, F Pauli, A Agarwal, ...
Cell 151 (2), 289-303, 2012
12392012
Robust synthetic circuits for two-dimensional control of gene expression in yeast
A Aranda-Díaz, K Mace, I Zuleta, P Harrigan, H El-Samad
ACS synthetic biology 6 (3), 545-554, 2017
722017
Multi-kinase control of environmental stress responsive transcription
K Mace, J Krakowiak, H El-Samad, D Pincus
PloS one 15 (3), e0230246, 2020
182020
Generating real-world data from health records: design of a patient-centric study in multiple sclerosis using a commercial health records platform
G Hanson, T Chitnis, MJ Williams, RW Gan, L Julian, K Mace, J Chia, ...
JAMIA open 5 (1), ooab110, 2022
32022
eP495: Introduction to Odyssey: Real-world rare disease data collection program for patients with long-chain fatty acid oxidation disorders in the US
E Kruger, E Yang, B Reineking, N Thomas, K Mace, M Tierney, E Cibelli, ...
Genetics in Medicine 24 (3), S315, 2022
12022
Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD odyssey program
E Yang, E Kruger, D Yin, K Mace, M Tierney, N Liao, E Cibelli, D Drozd, ...
Molecular Genetics and Metabolism, 108350, 2024
2024
A Fully Enrolled, Novel, Patient-Centred Real-World Evidence Study Designed to Better Understand Active and Nonactive Progressive Multiple Sclerosis Using Health Records in the …
C Watson, K Kresa-Reahl, S Bogdanovich, N Phillips, K Mace, ...
MULTIPLE SCLEROSIS JOURNAL 29, 702-703, 2023
2023
P041: Real-world major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States
E Yang, E Kruger, K Deering, D Yin, K Mace, N Liao, M Tierney, E Cibelli, ...
Genetics in Medicine Open 1 (1), 2023
2023
COVID-19 vaccination patterns and outcomes among persons with multiple sclerosis in the FlywheelMS cohort
C Geiger, D Sheinson, D Boudreau, K Mace, G Hanson, K Belendiuk, ...
Multiple Sclerosis Journal 28 (3_ SUPPL), 872-872, 2022
2022
CO42 Major Clinical Manifestations and Events Among Patients with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) in the United States: Real-World Results from LC-FAOD Odyssey
E Yang, E Kruger, K Deering, C Stubbe, K Mace, M Tierney, E Cibelli, ...
Value in Health 25 (7), S311-S312, 2022
2022
FlywheelMS: Stratification of Anxiety and Depression by MS Subtype as Captured in Digitized Health Records
K Zalocusky, R Gan, S Rizzo, K Belendiuk, L Gaetano, J Goldberg, ...
MULTIPLE SCLEROSIS JOURNAL 27 (1_ SUPPL), 91-92, 2021
2021
Engineering and Reverse Engineering of the Yeast Regulatory Network
K Mace
University of California, San Francisco, 2021
2021
Collecting real world mri in ms: preliminary results from flywheelms
A Traboulsee, W Van Hecke, D Smeets, G Hanson, K Mace, A Rovira, ...
MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 525-525, 2020
2020
A Patient-Centric Approach to Improve the Understanding of Sickle Cell Disease Using Real-World Data
ELJ Clay, M Bailey, D Drozd, J Paulose, N Ramscar, K Mace, D Wormser
Blood 136, 27-28, 2020
2020
Flywheelms: the prevalence of multiple sclerosis subtypes in digitized health records
RW Gan, S Rizzo, J Chia, G Hanson, K Mace, L Julian, L Gaetano, ...
MULTIPLE SCLEROSIS JOURNAL 26 (3_ SUPPL), 534-534, 2020
2020
FlywheelMS: a novel, patient-centred study to better understand multiple sclerosis using electronic health records and other real-world data sources
K Belendiuk, L Julian, M Martinec, K Mace, R Gan, L Gaetano, G Hanson, ...
MULTIPLE SCLEROSIS JOURNAL 25, 386-386, 2019
2019
FlywheelMS–A Novel Patient-Centered Approach to Collect and Integrate Real-World Clinical, Imaging and Digital Outcome Data in Patients With Multiple Sclerosis in the US
K Belendiuk, D Wormser, L Julian, M Martinec, K Mace, M Baker, ...
Hemoglobin 18 (25), 45, 2019
2019
Identification and use of treatment (tx) options in patients (pts) with advanced non-small cell lung cancer (aNSCLC) after comprehensive genomic profiling (CGP): A real-world …
C Mascaux, L Bubendorf, F Barlesi, JW Clendening, Q Zhang, K Mace, ...
Journal of Clinical Oncology 37 (15_suppl), 9076-9076, 2019
2019
SCORCh. R: Clustering and visualization of sequencing derived multiple transcription factor loci
K Mace, A Madar, M Ciofani, A Agarwal, A Greenfield, D Littman, ...
New York University, 2005
2005
The system can't perform the operation now. Try again later.
Articles 1–19